As hepatitis B research progresses, achieving higher functional cure rates is becoming more feasible. It is vital that policymakers set clear elimination targets for hepatitis B, coordinate efforts, enhance surveillance, and create supportive regulatory environments to support this.

A federal vaccine advisory committee this week is expected to discuss whether newborns should still get the hepatitis B vaccine — the first shot found to prevent cancer

A University of Minnesota-led review is urging federal health advisers to maintain a longstanding immunization strategy that has hepatitis B on the verge of elimination in the U.S. Offering vaccinations within 24 hours of birth is a safe and effective way to prevent the spread of the infectious disease,

Robert F. Kennedy Jr.'s vaccine advisers will vote this week on whether to delay hepatitis B shots for most American children, the new chair of the committee said, a move that would be the most consequential change since the health secretary began remaking vaccine policy.

The nation's top vaccine advisory panel is expected to debate on Thursday whether to delay the first dose of the hepatitis B shot.

The new chair of the Advisory Committee on Immunization Practices said the panel plans to vote to end universal hepatitis B vaccination at birth and to scrutinize if childhood shots cause allergies.